Clinical trial
HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients
NCT02312362 is registered in ClinicalTrials.gov with Oertli Instrumente AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients
- Lead sponsor
- Oertli Instrumente AG
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2012
- Completion date
- December 31, 2016
- Enrollment
- 108 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.